Investor Backing & Capital Strength:
An $80M Series C in April 2026 lifted total capital above $160M and put valuation near $1B, indicating strong capacity to fund AI and platform expansion. Participation from established investors (e.g., StepStone, Benchmark, Redpoint, ICONIQ, Atreides) reinforces financing stability.
Market Expansion:
Customer adoption progressed to 500+ MedTech companies, including 16 of the top 20, up from milestones like 300 customers in 2025. Enterprise penetration across leading manufacturers underscores widening reach in its target vertical.
Product Line Growth:
New offerings such as Care Journeys (launched 2024, expanded 2025), a Salesforce AppExchange product, a Snowflake Data Mart, and AcuityAI signal ongoing investment to broaden use cases. Expansion beyond commercial workflows toward the full product lifecycle further extends the platform’s scope.
